ALGS·01626L204·US·equity·Healthcare - Biotechnology-Activist
ALGS (Aligos Therapeutics, Inc.) is held by 28 institutional investors as of Q4 2025. Largest holders: Alyeska Investment Group, L.P. ($3.8M), Woodline Partners LP ($2.7M), MARSHALL WACE, LLP ($2.5M). Net institutional sentiment: Mixed.
See how ALGS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer